BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 32294179)

  • 1. Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications.
    Drucker DJ
    Endocr Rev; 2020 Jun; 41(3):. PubMed ID: 32294179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?
    Filardi T; Morano S
    J Endocrinol Invest; 2020 Aug; 43(8):1053-1060. PubMed ID: 32495299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?
    Bassendine MF; Bridge SH; McCaughan GW; Gorrell MD
    J Diabetes; 2020 Sep; 12(9):649-658. PubMed ID: 32394639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.
    Dastan F; Abedini A; Shahabi S; Kiani A; Saffaei A; Zare A
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):10-12. PubMed ID: 32534505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk.
    Öztürk AB; Çağlayan B
    Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):282-285. PubMed ID: 32914945
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 challenging cell biology.
    Bullerdiek J
    Protoplasma; 2020 May; 257(3):619-620. PubMed ID: 32333127
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of dipeptidyl peptidase-4 inhibitors in patients with diabetes infected with coronavirus-19.
    Chen CF; Chien CH; Yang YP; Chou SJ; Wang ML; Huo TI; Lin CC
    J Chin Med Assoc; 2020 Aug; 83(8):710-711. PubMed ID: 32349031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Proteomic Analysis of the Expression of SARS-CoV-2 Receptors in the Gut of Patients with Chronic Enterocolitis.
    Park J; Jeong D; Chung YW; Kim DH; Cheon JH; Ryu JH
    Yonsei Med J; 2020 Oct; 61(10):891-894. PubMed ID: 32975064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
    Chen L; Li X; Chen M; Feng Y; Xiong C
    Cardiovasc Res; 2020 May; 116(6):1097-1100. PubMed ID: 32227090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19.
    Choudhary S; Sreenivasulu K; Mitra P; Misra S; Sharma P
    Ann Lab Med; 2021 Mar; 41(2):129-138. PubMed ID: 33063674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
    Delpino MV; Quarleri J
    Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?
    Jagat J M; Kalyan K G; Subir R
    Diabetes Metab Syndr; 2020; 14(5):829-831. PubMed ID: 32540737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
    Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
    Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
    Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19.
    Solerte SB; Di Sabatino A; Galli M; Fiorina P
    Acta Diabetol; 2020 Jul; 57(7):779-783. PubMed ID: 32506195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights.
    Stoian AP; Papanas N; Prazny M; Rizvi AA; Rizzo M
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):494-496. PubMed ID: 32618198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits.
    Rao S; Lau A; So HC
    Diabetes Care; 2020 Jul; 43(7):1416-1426. PubMed ID: 32430459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and diabetes: Can DPP4 inhibition play a role?
    Iacobellis G
    Diabetes Res Clin Pract; 2020 Apr; 162():108125. PubMed ID: 32224164
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical analysis of sinus bradycardia in patients with severe COVID-19 pneumonia.
    Hu L; Gong L; Jiang Z; Wang Q; Zou Y; Zhu L
    Crit Care; 2020 May; 24(1):257. PubMed ID: 32456695
    [No Abstract]   [Full Text] [Related]  

  • 20. Combating sars-cov-2 through lipoxins, proteasome, caveolin and nuclear factor-κb pathways in non-pregnant and pregnant populations.
    Celik O; Celik N; Aydin S; Baysal B; Aydin S; Saglam A; Gursu Y; Dalkilic S; Ulas M; Ozcil MD; Tayyar AT; Cengiz F; Ugur K; Akkoc RF; Ersahin AA
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):221-229. PubMed ID: 32538775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.